View all cases
UPC APP 43687/2024
Jul 29, 2024·EP3167888 Unitary patent · TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
- Case details
- StatusCase ClosedActionGenericCategoryOther procedural
- Parties
- Claimants
- Amgen Technology (Ireland) Unlimited CompanyOperating co.
Representatives- Tilman Mueller-Stoy-Bardehle Pagenberg
- Division
- Hamburg LD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- English
- EPO Opposition
- Samsung Bioepis NL B.V.Withdrawn2024-05-02
- Amgen Technology (Ireland) Unlimited CompanyWithdrawn2024-10-28
- Salute HC Ilaç Pazarlama A.S.Admissible2025-01-31
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Hamburg LD | Locked |
| Judge Sabine Klepsch | Locked |
| Judge Alima Zana | Locked |
| Judge Stefan Schilling | Locked |
| Judge Rudi Goedeweeck | Locked |
At the UPC: Amgen Group (19 cases)·AstraZeneca Group (13 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 2 other proceedings
6 other defendants litigating the same or a related patent
UPC CoA 744/2025·UPC CFI 674/2025·UPC CFI 51/2025·UPC CFI 642/2024·UPC CoA 402/2024 and 1 more
Start a free trial to see how each one ended.
More cases: Hamburg LD·2024
Documents
Show all 62 documents| Document title | Date | Public |
|---|---|---|
| Case closed | 2025-12-05 | Not public |
| Order | 2025-12-02 | Not public |
| Order | 2025-12-02 | Not public |
| Cover sheet | 2025-11-26 | Not public |
| Further pleadings | 2025-11-26 | Not public |
| Further pleadings | 2025-11-26 | Not public |
| Receipt | 2025-11-26 | Not public |
| Cover sheet | 2025-11-25 | Not public |
| Other document Claimant | 2025-11-25 | Not public |
| Receipt | 2025-11-25 | Not public |